RxDoctor Payments Data

Marlon Quinones, MD

Psychiatry · San Antonio, TXNPI 1700083797

Payments from drug & device makers

$2,167in general payments, 2019–2025

Across 71 payments — averaging $30.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$1K
  • Janssen Scientific Affairs, LLC$215
  • Teva Pharmaceuticals USA, Inc.$201
  • Axsome Therapeutics, Inc.$149
  • Merz North America, Inc.$119
  • Alkermes, Inc.$100
  • plus $365 from 11 others

What the payments were for

  • Food & beverage$2,11498%
  • Education$532%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,167 in reported general payments places this provider in the 75th percentile of 2,238 psychiatry providers in Texas.

See all psychiatry providers in Texas

Medicare billing

Part B allowed, 2024
$65,467
Medicare patients
69
Services billed
484

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
SpravatoEsketamine Hcl1,549$1,931,277
VraylarCariprazine Hcl103$164,754
AustedoDeutetrabenazine27$154,949
Invega TrinzaPaliperidone Palmitate12$117,486
BelsomraSuvorexant193$89,619
RexultiBrexpiprazole50$73,631
Invega SustennaPaliperidone Palmitate29$73,500
AristadaAripiprazole Lauroxil14$50,086
Ramelteon469$46,393
Abilify MaintenaAripiprazole14$41,594
Hydroxyzine Hcl948$36,639
Desvenlafaxine Succinate ErDesvenlafaxine Succinate423$30,226
AuvelityDextromethorphan Hbr/Bupropion26$29,181
Aripiprazole676$28,654
TrintellixVortioxetine Hydrobromide35$18,908

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonSpravato, Invega Trinza, Invega Sustenna$1,018$2,122,2621,590 claims
Teva Pharmaceuticals USA, Inc.Austedo$201$154,94927 claims
Otsuka America Pharmaceutical, Inc.Rexulti, Abilify Maintena$49$115,22564 claims
Alkermes, Inc.Aristada$100$50,08614 claims
Axsome Therapeutics, Inc.Auvelity$149$29,18126 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix, Vyvanse$19$24,09948 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,238 psychiatry providers in Texas.

Other psychiatry in San Antonio

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →